Suppr超能文献

慢性阻塞性肺疾病(COPD)患者肺功能随年龄增长的年度下降情况。

Age-related annual decline of lung function in patients with COPD.

作者信息

Kim Soo Jung, Lee Jinwoo, Park Young Sik, Lee Chang-Hoon, Yoon Ho Il, Lee Sang-Min, Yim Jae-Joon, Kim Young Whan, Han Sung Koo, Yoo Chul-Gyu

机构信息

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea.

出版信息

Int J Chron Obstruct Pulmon Dis. 2015 Dec 30;11:51-60. doi: 10.2147/COPD.S95028. eCollection 2016.

Abstract

BACKGROUND

According to the Fletcher-Peto curve, rate of decline in forced expiratory volume in 1-second (FEV1) accelerates as age increases. However, recent studies have not demonstrated that the rate of FEV1 decline accelerates with age among COPD patients. The objective of the study is to evaluate annual rate of FEV1 decline as age increases among COPD patients.

METHODS

In this retrospective cohort study, we enrolled COPD patients who were followed up at two tertiary care university hospitals from January 2000 to August 2013. COPD was defined as post-bronchodilator (BD) FEV1/forced vital capacity (FVC) of <0.7. All participants had more than two spirometries, including BD response. Age groups were categorized as follows: below versus above median age or four quartiles.

RESULTS

A total of 518 participants (94.2% male; median age, 67 years; range, 42-90 years) were included. Mean absolute and predictive values of post-BD FEV1 were 1.57±0.62 L and 52.53%±18.29%, respectively. Distribution of Global initiative for Chronic Obstructive Lung Disease groups did not show statistical differences between age groups categorized by two different criteria. After grouping the population by age quartiles, the rate of FEV1 decline was faster among older patients than younger ones whether expressed as absolute value (-10.60±5.57 mL/year, -15.84±6.01 mL/year, -18.63±5.53 mL/year, 32.94±6.01 mL/year, respectively; P=0.048) or predicted value (-0.34%±0.19%/year, -0.53%±0.21%/year, -0.62%±0.19%/year, -1.26%±0.21%/year, respectively, P=0.010).

CONCLUSION

As suggested conceptually by the Fletcher-Peto curve, annual FEV1 decline among COPD patients is accelerated among older patients than younger ones.

摘要

背景

根据弗莱彻 - 佩托曲线,一秒用力呼气容积(FEV1)的下降速率随年龄增长而加快。然而,最近的研究并未证明慢性阻塞性肺疾病(COPD)患者中FEV1的下降速率会随年龄增长而加快。本研究的目的是评估COPD患者中随着年龄增长FEV1的年下降速率。

方法

在这项回顾性队列研究中,我们纳入了2000年1月至2013年8月在两家三级医疗大学医院接受随访的COPD患者。COPD定义为支气管扩张剂(BD)后FEV1/用力肺活量(FVC)<0.7。所有参与者均进行了两次以上的肺功能测试,包括BD反应。年龄组分类如下:低于与高于年龄中位数或四个四分位数。

结果

共纳入518名参与者(男性占94.2%;年龄中位数为67岁;范围为42 - 90岁)。BD后FEV1的平均绝对值和预测值分别为1.57±0.62 L和52.53%±18.29%。慢性阻塞性肺疾病全球倡议组织分组在按两种不同标准分类的年龄组之间未显示出统计学差异。按年龄四分位数对人群进行分组后,无论以绝对值(分别为-10.60±5.57 mL/年,-15.84±6.01 mL/年,-18.63±5.53 mL/年,-32.94±6.01 mL/年;P = 0.048)还是预测值(分别为-0.34%±0.19%/年,-0.53%±0.21%/年,-0.62%±0.19%/年,-1.26%±0.21%/年,P = 0.010)表示,老年患者中FEV1的下降速率均比年轻患者更快。

结论

正如弗莱彻 - 佩托曲线在概念上所提示的,COPD患者中,老年患者的FEV1年下降速率比年轻患者更快。

相似文献

1
Age-related annual decline of lung function in patients with COPD.
Int J Chron Obstruct Pulmon Dis. 2015 Dec 30;11:51-60. doi: 10.2147/COPD.S95028. eCollection 2016.
3
Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.
Eur Respir J. 2014 Aug;44(2):324-31. doi: 10.1183/09031936.00208613. Epub 2014 Apr 2.
4
Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Int J Chron Obstruct Pulmon Dis. 2015 Feb 23;10:407-14. doi: 10.2147/COPD.S76047. eCollection 2015.
5
The impact of heart failure on the classification of COPD severity.
J Card Fail. 2012 Aug;18(8):637-44. doi: 10.1016/j.cardfail.2012.05.008. Epub 2012 Jul 13.
6
Irreversible airway obstruction in adulthood after bronchiolitis in infancy: evidence from a 30-year follow-up study.
Respir Med. 2014 Jan;108(1):218-23. doi: 10.1016/j.rmed.2013.11.014. Epub 2013 Dec 2.
8
Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
Int J Chron Obstruct Pulmon Dis. 2015 Jun 25;10:1213-8. doi: 10.2147/COPD.S85166. eCollection 2015.
9
Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis. 2017 Apr 10;12:1119-1124. doi: 10.2147/COPD.S133071. eCollection 2017.

引用本文的文献

1
Prevalence and clinical correlates of chronic obstructive pulmonary disease in heart failure patients: a cross-sectional study in China.
Front Med (Lausanne). 2025 Feb 3;12:1477388. doi: 10.3389/fmed.2025.1477388. eCollection 2025.
3
The influencing of obesity on lung ventilation function among middle-aged and elderly people.
Sci Rep. 2024 Dec 30;14(1):31954. doi: 10.1038/s41598-024-83464-7.
5
Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease Among Users of Primary Health Care Facilities in Morocco.
Int J Chron Obstruct Pulmon Dis. 2024 Feb 5;19:375-387. doi: 10.2147/COPD.S443081. eCollection 2024.
7
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement.
Int J Chron Obstruct Pulmon Dis. 2023 Oct 10;18:2225-2243. doi: 10.2147/COPD.S396945. eCollection 2023.
8
Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function.
Respir Res. 2023 Feb 2;24(1):40. doi: 10.1186/s12931-023-02343-3.
9
Re-Defining High Risk COPD with Parameter Response Mapping Based on Machine Learning Models.
Int J Chron Obstruct Pulmon Dis. 2022 Oct 4;17:2471-2483. doi: 10.2147/COPD.S369904. eCollection 2022.

本文引用的文献

2
FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.
Am J Respir Crit Care Med. 2014 Nov 1;190(9):996-1002. doi: 10.1164/rccm.201404-0720OC.
3
Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.
Eur Respir J. 2014 Aug;44(2):324-31. doi: 10.1183/09031936.00208613. Epub 2014 Apr 2.
4
5
Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD.
Respir Med. 2013 Dec;107(12):1904-11. doi: 10.1016/j.rmed.2013.08.001. Epub 2013 Aug 22.
6
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9.
7
Lung function decline in COPD.
Int J Chron Obstruct Pulmon Dis. 2012;7:95-9. doi: 10.2147/COPD.S27480. Epub 2012 Feb 9.
8
Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2012 Jan 1;185(1):44-52. doi: 10.1164/rccm.201106-0992OC.
9
Changes in forced expiratory volume in 1 second over time in COPD.
N Engl J Med. 2011 Sep 29;365(13):1184-92. doi: 10.1056/NEJMoa1105482. Epub 2011 Sep 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验